GM beats Wall Street’s third-quarter estimates, guides toward ‘high end’ of 2021 earnings forecast

Earnings

In this article

The GM logo is seen on the facade of the General Motors headquarters in Detroit, Michigan, March 16, 2021.
Rebecca Cook | Reuters

DETROIT – General Motors announces third-quarter earnings before the markets open Wednesday.

Here’s what Wall Street expects, based on average analysts’ estimates compiled by Refinitiv.

  • Adjusted EPS: 96 cents a share
  • Revenue: $26.51 billion

The third-quarter was expected to be a rougher one than the first half of the year for GM. Analysts, however, say they expect relatively solid results, despite a global shortage of semiconductor chips that has depleted vehicle inventories and shuttered plants.

GM previously warned investors that its North American wholesale volumes would be down by about 200,000 units in the second half of 2021 compared with the first half, due to the parts problem.

The Detroit automaker has maintained its financial guidance for the year, including adjusted earnings of between $11.5 billion and $13.5 billion, or $5.40 to $6.40 a share. It earned about $6.2 billion, or $4.21 a share, during the first six months of the year.

In August, GM CFO Paul Jacobson said the automaker expected to take a hit of between $3.5 billion to $4.5 billion during the second half of the year, due to a $1.5 billion to $2 billion rise in commodity costs and lower earnings from its financial arm.

GM reported a net profit of $4 billion and an adjusted pretax gain of $5.3 billion during the third quarter of 2020. That was when dealerships and plants largely reopened after being shuttered during the second-quarter due to the coronavirus pandemic.

Shares of GM are up by 37.5% in 2021.

Articles You May Like

Moderna says FDA delayed RSV vaccine approval to end of May
‘I feel like I’ve been tricked’: Some property buyers in China’s Tianjin have been waiting 8 years for their homes
Beer giant AB InBev beats profit estimates, with Bud Light boycott set to ease one year on
Jim Simons, billionaire quantitative investing pioneer who generated eye-popping returns, dies at 86
Novavax shares nearly double on Sanofi deal to commercialize Covid vaccine, develop combination shots

Leave a Reply

Your email address will not be published. Required fields are marked *